why choose us

First received: March 12, 2024

Clinical Trial: Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Blinded, Placebo-controlled, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of ITK Inhibitor Soquelitinib in Participants

Brief Summary: Safety, tolerability, and preliminary efficacy of soquelitinib in participants with moderate to severe AD

Read more